Retrospective Study on Radiological Factors Predictive of Psoas

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05720806` - Weight Bearing Status Post-hip Arthroscopy	N/A
Completed	`NCT05310240` - Analysis of the Relevance of Radiologic Parameters on the Outcome After Hip Arthroscopy
Withdrawn	`NCT05710146` - Tranexamic Acid (TXA) in Hip Arthroscopy	Phase 3
Terminated	`NCT04212650` - Losartan to Improve Hip Microfracture	Phase 1/Phase 2

See also

Status

Clinical Trial

Phase

Enrolling by invitation

NCT05720806 - Weight Bearing Status Post-hip Arthroscopy

N/A

Completed

NCT05310240 - Analysis of the Relevance of Radiologic Parameters on the Outcome After Hip Arthroscopy

Withdrawn

NCT05710146 - Tranexamic Acid (TXA) in Hip Arthroscopy

Phase 3

Terminated

NCT04212650 - Losartan to Improve Hip Microfracture

Phase 1/Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05893823
Study type	Observational
Source	Istituto Ortopedico Rizzoli
Contact	Federica Mariotti, MD
Phone	+390516366281
Email	federica.mariotti@ior.it
Status	Recruiting
Phase
Start date	June 6, 2022
Completion date	September 30, 2024

Retrospective Study on Radiological Factors Predictive of Psoas Impingement

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms